Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma Progression”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Testing effectiveness (Phase 2)Looking for participantsNCT07109323
What this trial is testing

Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM

Who this might be right for
Ultra High Risk mm (uhr-mm), 18-70 Years Old, Suitable for ASCT. And Meet Any of the Following uhr-mm DefinitionsCytogenetics Ultra High RiskPrimary Refractory+4 more
Institute of Hematology & Blood Diseases Hospital, China 50
Early research (Phase 1)WithdrawnNCT06411301
What this trial is testing

A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors

Who this might be right for
Multiple Myeloma, RefractoryMultiple Myeloma in RelapseMultiple Myeloma Progression
Jules Bordet Institute
Not applicableStudy completedNCT00911105
What this trial is testing

Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone

Who this might be right for
Multiple Myeloma
iOMEDICO AG 101
Testing effectiveness (Phase 2)Ended earlyNCT01116128
What this trial is testing

Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients

Who this might be right for
Myeloma
Fondazione EMN Italy Onlus 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04850846
What this trial is testing

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 60
Not applicableLooking for participantsNCT02269592
What this trial is testing

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Myelodysplastic SyndromesHematological Malignancies+5 more
Dana-Farber Cancer Institute 10,000
Large-scale testing (Phase 3)Study completedNCT01109004
What this trial is testing

Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)

Who this might be right for
Multiple Myeloma
National Heart, Lung, and Blood Institute (NHLBI) 758
Not applicableStudy completedNCT05673967
What this trial is testing

Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals 62
Testing effectiveness (Phase 2)WithdrawnNCT06400264
What this trial is testing

Testing Nivolumab and BMS-986016 (Relatlimab) as Potentially Targeting Treatment in Cancers That Are LAG-3+ and Have Mismatch Repair Deficiency (MATCH - Subprotocol Z1M)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02135406
What this trial is testing

CART-19 for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 13
Large-scale testing (Phase 3)UnknownNCT01134484
What this trial is testing

VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Michele Cavo 480
Not applicableStudy completedNCT04137523
What this trial is testing

Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression

Who this might be right for
Multiple Myeloma
University of Turin, Italy 26
Not applicableStudy completedNCT01958528
What this trial is testing

Study Of Circulating Multiple Myeloma Cells As A Biomarker of MGUS And SMM

Who this might be right for
a Diagnosis of MGUS or SMM by IMWG Criteria
Abramson Cancer Center at Penn Medicine 52
Testing effectiveness (Phase 2)Study completedNCT00908232
What this trial is testing

Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD

Who this might be right for
Multiple Myeloma
Janssen-Cilag International NV 163
Large-scale testing (Phase 3)Study completedNCT02322320
What this trial is testing

Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)

Who this might be right for
Multiple Myeloma
National Heart, Lung, and Blood Institute (NHLBI) 273
Testing effectiveness (Phase 2)Ended earlyNCT00899353
What this trial is testing

Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple MyelomaChronic Lymphocytic Leukemia
Marshall University 16
Testing effectiveness (Phase 2)Study completedNCT01463670
What this trial is testing

Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 11
Large-scale testing (Phase 3)UnknownNCT03428373
What this trial is testing

Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma ProgressionMultiple Myeloma Stage II+3 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 57
Large-scale testing (Phase 3)Ended earlyNCT05675319
What this trial is testing

Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 28
Testing effectiveness (Phase 2)WithdrawnNCT02578121
What this trial is testing

UARK 2015-03 A Phase II Trial of a Novel Proteasome/IMiD Combination

Who this might be right for
Multiple Myeloma
University of Arkansas
Load More Results